A Phase I and Pharmacokinetic Study of Oral 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone(3-AP,Triapine) in the Treatment of Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2016
At a glance
- Drugs OCX 191 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 09 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2012 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.